Inicio › Leucemia linfocítica crónica › Ohio › Cincinnati
Ensayos clínicos de Leucemia linfocítica crónica en Cincinnati, OH
15 estudios para Leucemia linfocítica crónica buscan participantes en centros de Cincinnati y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ReclutandoFase 2
- Saint Elizabeth Medical Center Edgewood, Edgewood · A 8 mi de distancia
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ReclutandoFase 4
- Oncology Hematology Care Inc, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- y 3 más
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ReclutandoFase 2
- University of Cincinnati, Cincinnati
- Oncology Hematology Care, Fairfield · A 15 mi de distancia
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
ReclutandoFase 3
- Oncology Hematology Care Clinical Trials, Llc, Cincinnati
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
ReclutandoFase 1
- University of Cincinnatti Medical Center, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ReclutandoFase 3
- University of Cincinnati Medical Center, Cincinnati
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
ReclutandoFase 3
- Saint Elizabeth Healthcare ( Site 0041), Edgewood · A 8 mi de distancia
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
ReclutandoFase 1
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- University of Cincinnati Medical Center, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutandoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
ReclutandoFase 2
- University of Cincinnati, Cincinnati
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
ReclutandoFase 2
- University of Cincinnati, Cincinnati
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
ReclutandoFase 2
- University of Cincinnati Medical Center, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
ReclutandoFase 1/2
- University of Cincinnati, Cincinnati
Ensayos de Leucemia linfocítica crónica en otras ciudades
- Boston, MA31 estudios
- Columbus, OH29 estudios
- Durham, NC28 estudios
- Washington, DC22 estudios
- Seattle, WA22 estudios
- Rochester, MN20 estudios
- New York City, NY20 estudios
- Houston, TX18 estudios
- Baldwin Park, CA18 estudios
- Milwaukee, WI15 estudios
- Chicago, IL14 estudios
- Nashville, TN13 estudios
Otros estudios en Cincinnati
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de seno24 estudios
- Fallo cardíaco22 estudios
- Cáncer metastásico21 estudios
- Cáncer del colon y del recto20 estudios
- Obesidad20 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de próstata19 estudios
- Cáncer de ovario18 estudios
- Cáncer de pulmón18 estudios
- Mieloma múltiple17 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.